Health Encyclopedia

Optic glioma

Definition

Gliomas are tumors that grow in various parts of the brain. Optic gliomas can affect:

One or both of the optic nerves that carry visual information to the brain from each eye
The optic chiasm, the area where the optic nerves cross each other in front of the hypothalamus of the brain

An optic glioma may also grow along with a hypothalamic glioma.

Alternative Names

Glioma - optic; Optic nerve glioma; Juvenile pilocytic astrocytoma; Brain cancer - optic glioma

Causes

Optic gliomas are rare. The cause of optic gliomas is unknown. Most optic gliomas are slow-growing and noncancerous (benign) and occur in children, almost always before age 20. Most cases are diagnosed by 5 years of age.

There is a strong association between optic glioma and neurofibromatosis type 1 (NF1).

Symptoms

The symptoms are due to the tumor growing and pressing on the optic nerve and nearby structures. Symptoms may include:

Involuntary eyeball movement
Outward bulging of one or both eyes
Squinting
Vision loss in one or both eyes that starts with the loss of peripheral vision and eventually leads to blindness

The child may show symptoms of diencephalic syndrome, which includes:

Daytime sleeping
Decreased memory and brain function
Headaches
Delayed growth
Loss of body fat
Vomiting

Exams and Tests

A brain and nervous system (neurologic) examination reveals a loss of vision in one or both eyes. There may be changes in the optic nerve, including swelling or scarring of the nerve, or paleness and damage to the optic disc.

The tumor may extend into deeper parts of the brain. There may be signs of increased pressure in the brain (intracranial pressure). There may be signs of neurofibromatosis type 1 (NF1).

The following tests may be performed:

Cerebral angiography
Examination of tissue removed from the tumor during surgery or CT scan-guided biopsy to confirm the tumor type
Head CT scan or MRI of the head
Visual field tests

Treatment

Treatment varies with the size of the tumor and the general health of the person. The goal may be to cure the disorder, relieve symptoms, or improve vision and comfort.

Surgery to remove the tumor may cure some optic gliomas. Partial removal to reduce the size of the tumor can be done in many cases. This will keep the tumor from damaging normal brain tissue around it. Chemotherapy may be used in some children. Chemotherapy may be especially useful when the tumor extends into the hypothalamus or if vision has been worsened by the tumor's growth.

Radiation therapy may be recommended in some cases when the tumor is growing despite chemotherapy, and surgery is not possible. In some cases, radiation therapy may be delayed because the tumor is slow growing. Children with NF1 usually won't receive radiation due to the side effects.

Corticosteroids may be prescribed to reduce swelling and inflammation during radiation therapy, or if symptoms return.

Support Groups

Organizations that provide support and additional information include:

Children's Oncology Group -- www.childrensoncologygroup.org
Neurofibromatosis Network -- www.nfnetwork.org

Outlook (Prognosis)

The outlook is very different for each person. Early treatment improves the chance of a good outcome. Careful follow-up with a care team experienced with this type of tumor is important.

Once vision is lost from the growth of an optic tumor, it may not return.

Normally, the growth of the tumor is very slow, and the condition remains stable for long periods. However, the tumor can continue to grow, so it must be monitored closely.

When to Contact a Medical Professional

Contact your health care provider for any vision loss, painless bulging of the eye, or other symptoms of this condition.

Prevention

Genetic counseling may be advised for people with NF1. Regular eye exams may allow early diagnosis of these tumors before they cause symptoms.

References

Eberhart CG. Eye and ocular adnexa. In: Goldblum JR, Lamps LW, McKenney JK, Myers JL, eds. Rosai and Ackerman's Surgical Pathology. 11th ed. Philadelphia, PA: Elsevier; 2018:chap 45.

Goodden J, Mallucci C. Optic pathway hypothalamic gliomas. In: Winn HR, ed. Youmans and Winn Neurological Surgery. 7th ed. Philadelphia, PA: Elsevier; 2017:chap 207.

Olitsky SE, Marsh JD. Abnormalities of the optic nerve. In: Kliegman RM, St. Geme JW, Blum NJ, Shah SS, Tasker RC, Wilson KM, eds. Nelson Textbook of Pediatrics. 21st ed. Philadelphia, PA: Elsevier; 2020:chap 649.

Review Date:10/28/2021
Reviewed By:Todd Gersten, MD, Hematology/Oncology, Florida Cancer Specialists & Research Institute, Wellington, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

The Agency for Health Care Administration (Agency) and this website do not claim the information on, or referred to by, this site is error free. This site may include links to websites of other government agencies or private groups. Our Agency and this website do not control such sites and are not responsible for their content. Reference to or links to any other group, product, service, or information does not mean our Agency or this website approves of that group, product, service, or information.

Additionally, while health information provided through this website may be a valuable resource for the public, it is not designed to offer medical advice. Talk with your doctor about medical care questions you may have.